C.-H. Chao et al. / Tetrahedron 64 (2008) 3554e3560
3559
3.3.5. Griffinisterone E (5)
Amorphous solid; [a]2D2 ꢀ8 (c 0.38, CHCl3); IR (KBr) vmax
3.5. In vitro anti-inflammatory assay
1700 and 1683 cmꢀ1
;
13C and 1H NMR data, see Tables 1 and
The anti-inflammatory assay was modified from Ho et al.11
and Park et al.12 Murine RAW264.7 macrophages were ob-
tained from the American Type Culture Collection (ATCC,
no. TIB-71) and cultured in Dulbecco’s modified essential me-
dium (DMEM) containing 10% heat-inactivated fetal bovine
serum, at 37 ꢁC in a humidified 5% CO2e95% air incubator
under standard conditions. The macrophage cells were plated
in 60 mm culture dishes (3ꢃ106 cells), and test compounds
were added to the culture medium for 16 h. Then, cells were
washed with ice-cold PBS, lysed in ice-cold lysis buffer, and
then centrifuged at 20,000g for 30 min at 4 ꢁC. The superna-
tant was decanted from the pellet and retained for Western
blot analysis. Protein concentrations were determined by the
DC protein assay kit (Bio-Rad) modified by the method of
Lowry et al.13 Samples containing equal quantities of protein
were subjected to SDSepolyacrylamide gel electrophoresis,
and the separated proteins were electrophoretically transferred
to polyvinylidene difluoride membranes (PVDF; Immobilon-P,
Millipore, 0.45 mm pore size). The resultant PVDF membranes
were incubated with blocking solution and incubated for
180 min with antibody against inducible nitric oxide synthase
(iNOS; 1:1000 dilution; Transduction Laboratories) and cyclo-
oxygenase-2 (COX-2; 1:1000 dilution; Cayman Chemical)
protein. The blots were detected using ECL detection reagents
(PerkineElmer, Western Blot Chemiluminescence Reagent
Plus) according to the manufacturer instructions. The mem-
branes were reprobed with a monoclonal mouse anti-b-actin
antibody (1:2500, Sigma) as the loading control. For the im-
munoreactivity data, the intensity of each drug-treated band
is expressed as the integrated optical density (IOD), calculated
with respect to the average optical density of the correspond-
ing control (LPS-only treatment) band. For statistical analysis,
all the data were analyzed by a one-way analysis of variance
(ANOVA), followed by the StudenteNewmaneKeuls post
hoc test for multiple comparisons. A significant difference
was defined as a P value of <0.05.
2; ESIMS m/z 437 [MþNa]þ; HRESIMS m/z 437.3027
[MþNa]þ (calcd for C27H42O3Na, 437.3031).
3.3.6. Preparation of (S) and (R)-PGME amides of 5
To a stirred solution of compound 5 (1 mg) and (S)-PGME
(2 mg) in a 1 mL mixture of CHCl3eDMF (10:1) were succes-
sively added DMAP (2 mg) and 4-DMAP$HCl (2 mg). After
the mixture was stirred at 0 ꢁC for 5 min, EDC$HCl (2 mg)
was added. The reaction mixture was then moved to a freezer
at 4 ꢁC for overnight. The mixture was then stirred at room
temperature for 3 h. Subsequently, ethyl acetate was added,
and the resulting solution was successively washed with 5%
HCl, saturated NaHCO3(aq), and brine. The organic layer
was dried over anhydrous Na2SO4 and concentrated to give
a residue, which was chromatographed on silica gel using
n-hexaneeEtOAc (8:1) as eluent to afford the (S)-PGME
amide (5a) (0.8 mg). The same procedure was used to prepare
the (R)-PGME amide (5b) (0.6 mg from 1 mg of 5) with (S)-
1
PGME. Selective H NMR (CDCl3) of 5a: dH 7.355 (5H, br
s, Ph), 7.044 (1H, d, J¼10.0 Hz, H-1), 6.467 (1H, d,
J¼7.2 Hz, NH), 5.831 (1H, d, J¼10.0 Hz, H-2), 5.610 (1H,
d, J¼7.2 Hz, CHeN), 3.735 (3H, s, OCH3), 1.650 (1H, m,
H-17), 1.443 (2H, m, H-22), 1.479 (1H, m, H-25), 0.946
(3H, s, H3-19), 0.834 (6H, d, J¼6.3 Hz, H3-26 and H3-27),
1
0.620 (3H, s, H3-18). Selective H NMR (CDCl3) of 5b: dH
7.339 (5H, br s, Ph), 7.104 (1H, d, J¼10.0 Hz, H-1), 6.460
(1H, d, J¼7.2 Hz, NH), 5.845 (1H, d, J¼10.0 Hz, H-2),
5.653 (1H, d, J¼7.2 Hz, CHeN), 3.749 (3H, s, OCH3),
1.682 (1H, m, H-17), 1.409 (2H, m, H-22), 1.381 (1H, m,
H-25), 0.988 (3H, s, H3-19), 0.755 (3H, s, H3-18), 0.748
(6H, d, J¼6.3 Hz, H3-26 and H3-27).
3.4. X-ray diffraction analysis of griffinisterone A (1)
A suitable colorless crystal (0.8ꢃ0.8ꢃ0.2 mm3) of 1 was
grown by slow evaporation of the acetone containing few drops
of benzene at 0 ꢁC. Diffraction intensity data were acquired
with a Rigaku AFC7S single-crystal X-ray diffractometer
with graphite-monochromated Mo Ka radiation (l¼
Acknowledgements
Financial support was provided by Ministry of Education
(95C030313) and National Science Council of Taiwan (NSC
95-2113-M-110-011-MY3) awarded to J.-H.S.
˚
0.71073 A). Crystal data for 1: C28H44O3 (formula weight
428.63), approximate crystal size, 0.8ꢃ0.8ꢃ0.2 mm3, mono-
˚
clinic, space group, P21 (#4), T¼298(2) K, a¼12.467(4) A, b¼
3
ꢁ
References and notes
˚
˚
˚
7.636(2) A, c¼14.244(5) A, b¼110.18(3) , V¼1272.7(7) A ,
Dc¼1.118 Mg/m3, Z¼2, F(000)¼472, m(Mo Ka)¼0.070 mmꢀ1
.
1. Yoshikawa, K.; Kanekuni, S.; Hanahusa, M.; Arihara, S.; Ohta, T. J. Nat.
Prod. 2000, 63, 670e672.
A total of 3426 reflections were collected in the range
1.88ꢁ<q<26.00ꢁ, with 2695 independent reflections [R(int)¼
0.0420], completeness to qmax was 99.9%; psi-scan empirical
absorption correction applied; full-matrix least-squares refine-
ment on F2, the number of data/restraints/parameters were
2695/1/293; goodness-of-fit on F2¼1.019; final R indices
[I>2s(I)], R1¼0.0436, wR2¼0.1106; R indices (all data), R1¼
0.0656, wR2¼0.1225, largest difference peak and hole, 0.139
2. Duh, C.-Y.; El-Gamal, A. A. H.; Song, P.-Y.; Wang, S.-K.; Dai, C.-F.
J. Nat. Prod. 2004, 67, 1650e1653.
3. Tomono, Y.; Hirota, H.; Fusetani, N. J. Org. Chem. 1999, 64, 2272e
2275.
4. Tomono, Y.; Hirota, H.; Imahara, Y.; Fusetani, N. J. Nat. Prod. 1999, 62,
1538e1541.
5. Aiello, A.; Fattorusso, E.; Menna, M. Steroids 1991, 56, 513e517.
6. Crystallographic data for compound 1 have been deposited with the Cam-
bridge Crystallographic Data Centre (deposition number CCDC 656887).
3
˚
and ꢀ0.227 e/A .